EMEA-001930-PIP01-16

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Neisseria meningitidis serogroup A polysaccharide conjugated to tetanus toxoid / N. meningitidis serogroup C polysaccharide conjugated to tetanus toxoid / N. meningitidis serogroup Y polysaccharide conjugated to tetanus toxoid / N. meningitidis serogroup W polysaccharide conjugated to tetanus toxoid (MenACYW)

Decision numberP/0359/2017
PIP numberEMEA-001930-PIP01-16
Pharmaceutical form(s)Solution for injection
Condition(s)/indication(s)

Prevention of meningococcal disease

Route(s) of administrationIntramuscular use
PIP applicant

Sanofi Pasteur Inc.
Tel. +33 437375038
E-mail: media@sanofipasteur.com
 

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision